SynthesisOral and maxillofacial surgery2026
Platelet-rich fibrin after mandibular third molar extraction: an umbrella review of systematic reviews and meta-analyses.
Synthesis in Oral and maxillofacial surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo synthesize evidence on platelet-rich fibrin (PRF) and its derivatives for postoperative outcomes after mandibular third molar extraction, and to re-evaluate the methodological quality of available systematic reviews against the prior umbrella review (Yang 2024).
methodsPubMed, Cochrane CDSR, and Epistemonikos were searched without language restriction up to May 2026. Systematic reviews evaluating PRF for mandibular third molar extraction outcomes were included. Two reviewers independently screened, extracted data, applied AMSTAR-2 under the strict algorithm, and computed the corrected covered area (CCA). Yang 2024 was excluded as comparator.
resultsNineteen systematic reviews were included, four post-dating Yang's cutoff. PRF consistently reduced alveolar osteitis (RR/OR 0.22-0.43) and postoperative pain (SMD - 0.38 to - 1.84). In the highest-quality network meta-analysis (Costa 2023), L-PRF effects on pain remained below the ~ 10-mm minimum clinically important difference (MCID), whereas A-PRF and CGF exceeded it. Effects on swelling were large but highly heterogeneous; effects on trismus and healing were derivative-dependent. Strict AMSTAR-2 classified 1/19 reviews as high, 1/19 as moderate, 8/19 as low, and 9/19 as critically low confidence. The CCA was 12.77% (high overlap). None of the nine reviews previously rated high by Yang reached high confidence in our evaluation.
conclusionPRF provides clinically meaningful benefits after mandibular third molar extraction, particularly for alveolar osteitis prevention and early pain control with A-PRF and CGF. However, the methodological quality of the underlying systematic-review evidence is substantially lower than previously characterized, and recommendations should be calibrated accordingly. PROTOCOL REGISTRATION: Open Science Framework (OSF), https://doi.org/10.17605/OSF.IO/ED4MJ , registered 21 May 2026.
Indexed as
Identifiers
42629517What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.